Literature DB >> 204325

Multicentric reticulohistiocytosis and malignant disease.

M D Catterall, J E White.   

Abstract

Multicentric reticulohistiocytosis developed in a 45-year-old woman, who had a 3 year history of untreated breast carcinoma. A review of the literature revealed that malignant disease has been associated with 27% of reported cases. It is considered that, like adult dermatomyositis, the onset of multicentric reticulohistiocytosis should stimulate detailed investigation for an underlying neoplasm.

Entities:  

Mesh:

Year:  1978        PMID: 204325     DOI: 10.1111/j.1365-2133.1978.tb01626.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

Review 1.  Multicentric reticulohistiocytosis: a rare yet challenging disease.

Authors:  Arshia D Islam; Stanley M Naguwa; Gurtej S Cheema; John C Hunter; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

2.  Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis.

Authors:  Daniel J Zinn; Olive Eckstein; Mary L Olsen; Carl E Allen; Kenneth L McClain
Journal:  Dermatol Case Rep       Date:  2019-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.